Changes in the phosphorylation status of eNOS have an impact on a large number of disease processes including atherosclerosis, hyperhomocysteine, myocardial infarction, reperfusion injury, cerebral ischemia, and erectile dysfunction (Kolluru, Siamwala & Chatterjee, 2010). This evidence concerns the gene NOS3 and atherosclerosis.